Differences of use between paliperidone palmitate 3 month and paliperidone palmitate 1 month in real practice, with psychotic patients

Differences of use between paliperidone palmitate 3 month and paliperidone palmitate 1 month in real practice, with psychotic patients

Introduction Paliperidone palmitate 1-month (PP1M) is a Long-acting injectable antipsychotic formulation, approved for the treatment of schizophrenia and schizoaffective disorder. Recently, paliperidone palmitate 3-months (PP3M) formulation was introduced, which maintains stability while offering a...

Full description

Bibliographic Details
Main Authors: P. Escobedo-Aedo, J. Merayo-Cano, L. Mata Iturralde, L. Muñoz Lorenzo, S. Ovejero, S. Sánchez Alonso
Format: Article
Language:English
Published: Cambridge University Press 2022-06-01
Series:European Psychiatry
Subjects:
Paliperidone palmitate
severity
Long-acting inyectable
Treatment
Online Access:https://www.cambridge.org/core/product/identifier/S0924933822018867/type/journal_article

Internet

https://www.cambridge.org/core/product/identifier/S0924933822018867/type/journal_article

Similar Items